PHARMACOLOGICAL CORRECTION OF METABOLIC SYNDROME AND CHRONIC KIDNEY DISEASE

PHARMACOLOGICAL CORRECTION OF METABOLIC SYNDROME AND CHRONIC KIDNEY DISEASE

Aim. Optimization of pharmacotherapy of patients with metabolic syndrome and chronic kidney disease according to the nephroprotective properties of antihypertensive drugs.Methods. 81 patients (38 male, 43 female, age 29-79 years, mean age 53,4± 11,6 years) with metabolic syndrome and normal kidney f...

Full description

Bibliographic Details
Main Authors: T. E. Morozova, E. M. Shilov, A. V. Beloborodova
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2022-12-01
Series:Сеченовский вестник
Subjects:
metabolic syndrome
chronic kidney disease
antihypertensive drugs
nephroprotection
glomerular filtration rate
microalbuminuria
Online Access:https://www.sechenovmedj.com/jour/article/view/660

Internet

https://www.sechenovmedj.com/jour/article/view/660

Similar Items